These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Lipid and smooth muscle architectural pathology in the rabbit atherosclerotic vessel wall using Q-space cardiovascular magnetic resonance. Taylor EN; Huang N; Lin S; Mortazavi F; Wedeen VJ; Siamwala JH; Gilbert RJ; Hamilton JA J Cardiovasc Magn Reson; 2022 Dec; 24(1):74. PubMed ID: 36544161 [TBL] [Abstract][Full Text] [Related]
29. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature? Chiorescu RM; Mocan M; Inceu AI; Buda AP; Blendea D; Vlaicu SI Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362423 [TBL] [Abstract][Full Text] [Related]
30. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis. Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175 [TBL] [Abstract][Full Text] [Related]
31. CD40 signaling in vascular cells: a key role in atherosclerosis? Mach F; Schönbeck U; Libby P Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547 [TBL] [Abstract][Full Text] [Related]
32. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. Fernández-Ortiz A; Badimon JJ; Falk E; Fuster V; Meyer B; Mailhac A; Weng D; Shah PK; Badimon L J Am Coll Cardiol; 1994 Jun; 23(7):1562-9. PubMed ID: 8195515 [TBL] [Abstract][Full Text] [Related]
33. [Coronary atherosclerosis and progression to unstable plaques : Histomorphological and molecular aspects]. Wohlschlaeger J; Bertram S; Theegarten D; Hager T; Baba HA Herz; 2015 Sep; 40(6):837-44. PubMed ID: 26216542 [TBL] [Abstract][Full Text] [Related]
34. Platelets in atherosclerosis and thrombosis. Schulz C; Massberg S Handb Exp Pharmacol; 2012; (210):111-33. PubMed ID: 22918729 [TBL] [Abstract][Full Text] [Related]
35. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention. Chapman MJ Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923 [TBL] [Abstract][Full Text] [Related]
36. The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease. Ascher S; Reinhardt C Eur J Immunol; 2018 Apr; 48(4):564-575. PubMed ID: 29230812 [TBL] [Abstract][Full Text] [Related]
37. [Basic research of fibrosis on atherosclerotic plaque stability and related drug application]. Yin J; Li Q; Zhao Z; Yang Q; Li YJ; Chen Y; Wang YJ; Weng XG; Cai WY; Zhu XX Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):235-241. PubMed ID: 30989939 [TBL] [Abstract][Full Text] [Related]
38. The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor? Cimmino G; D'Amico C; Vaccaro V; D'Anna M; Golino P Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):517-23. PubMed ID: 21517734 [TBL] [Abstract][Full Text] [Related]
39. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist. Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243 [TBL] [Abstract][Full Text] [Related]